Cytokinetics | CYTK - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Amgen USD 24.96B 534M 2026-03
Arca Biopharma USD 15.37M 5.59M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Biogen USD 3B 350.5M 2026-03
Brainstorm Cell Therapeutics USD 11.01M 1.98M 2025-12
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Capricor Therapeutics USD 35.84M 7.69M 2025-12
Cytokinetics USD 199.18M 3.27M 2026-03
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Exelixis USD 405.64M 31.86M 2025-12
Geron USD 113.82M 26.11M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Ionis Pharmaceuticals USD 717M 66M 2026-03
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03